Pulse nav.journalClub Trends Entdecken Fragen Forschende

Download the App

Join discussions, follow papers, and never miss your next session.

© Synapse Social LLC, 2026Datenschutz

Start Entdecken nav.journalClub Trends

⌘+K

Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease | Synapse

May 6, 1999Open Access

Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease

Key Points

Key points are not available for this paper at this time.

Abstract

Infliximab is an efficacious treatment for fistulas in patients with Crohn's disease.

Read Full Paperexternally

Like

Bookmark

Share

View Full Paper

Like

Bookmark

Share

View Full Paper

Cite This Study

Present et al. (Thu,) studied this question.

synapsesocial.com/papers/69d896568c03fbaff8bef8db https://doi.org/https://doi.org/10.1056/nejm199905063401804

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Gastroduodenal Crohn's disease: The focus is on focality1997 · 34 citations
2Healing of perineal Crohn's disease with metronidazole1980 · 443 citations
3[Anal complications of Crohn's disease].1971 · 161 citations
4Rapid closure of Crohn's disease fistulas with continuous intravenous cyclosporin A.1993 · 240 citations
5Tumour necrosis factor alpha in stool as a marker of intestinal inflammation1992 · 696 citations